Quest Diagnostics 2012 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2012 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 126

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126

42
SELECTED HISTORICAL FINANCIAL DATA OF OUR COMPANY
The following table summarizes selected historical financial data of our Company and our subsidiaries at the dates and
for each of the periods presented. We derived the selected historical financial data for the years 2008 through 2012 from the
audited consolidated financial statements of our Company. During the fourth quarter of 2012, we sold our OralDNA salivary
diagnostics business, and committed to a plan to sell our HemoCue diagnostic products business. In February 2013, we entered
into an agreement to sell HemoCue. During the third quarter of 2006, we completed the wind down of NID, a test kit
manufacturing subsidiary. As a result, the operations for HemoCue, OralDNA and NID have been classified as discontinued
operations. At December 31, 2012, the assets and liabilities of HemoCue have been reported as held for sale in the accompanying
consolidated balance sheets included in this Annual Report on Form 10-K. The selected historical financial data presented below has
been recast to report the results of HemoCue and OralDNA as discontinued operations for all periods presented. The selected
historical financial data is only a summary and should be read together with the audited consolidated financial statements and
related notes of our Company and management's discussion and analysis of financial condition and results of operations
included elsewhere in this Annual Report on Form 10-K.